Skip to main content
Linical Co., Ltd. logo

Linical Co., Ltd. — Investor Relations & Filings

Ticker · 2183 ISIN · JP3974530002 T Professional, scientific and technical activities
Open in API
Filings indexed 60 across all filing types
Latest filing 2024-02-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 2183

About Linical Co., Ltd.

https://www.linical.com/

Linical is a global Contract Research Organization (CRO) providing a full spectrum of drug development services to biopharmaceutical companies. The company supports clinical trials from early-stage research to large-scale, multinational studies (Phase I-IV). Its services include clinical trial strategy, consulting, monitoring, and quality control. Linical focuses on a collaborative approach to guide clients through the clinical development process, aiming to expedite timelines and achieve enrollment goals without compromising quality.

Recent filings

Filing Released Lang Actions
四半期報告書－第19期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter (第３四半期) of the 19th fiscal period, filed by Linical Co., Ltd. with the Kinki Finance Bureau. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as segment information and notes to the financial statements. Since it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report (IR). 9M 2024
2024-02-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is titled "第２四半期報告書" (Second Quarter Report) and explicitly confirms the appropriateness of the contents for the second quarter period (July 1, 2023, to September 30, 2023). This structure, focusing on a specific interim financial period and signed off by management, strongly indicates a comprehensive quarterly financial report, which aligns with the definition of an Interim / Quarterly Report (IR). The document length is very short (571 chars), but the content is the substance of the certification/confirmation regarding the report's accuracy, not just an announcement of its publication. Given the explicit reference to the 'Quarterly Report' content verification for an interim period, 'IR' is the most appropriate classification over a general 'RPA' or 'RNS'.
2023-11-14 Japanese
四半期報告書－第19期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Linical Co., Ltd. covering the second quarter of the 19th fiscal period (April 1, 2023, to September 30, 2023). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management analysis and shareholding information. This fits the definition of an Interim/Quarterly Report (IR). H1 2024
2023-11-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the First Quarter Report (Dai-ichi shihanki hokokusho). While it references a quarterly report, the document itself is a formal regulatory confirmation statement filed with the Kinki Local Finance Bureau. Since it is a specific regulatory filing required by law to accompany financial reports and does not fit into the primary financial report categories, it is classified as a Regulatory Filing (RNS).
2023-08-14 Japanese
四半期報告書－第19期第1四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Linical Co., Ltd. covering the period from April 1, 2023, to June 30, 2023. It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as segment information and notes to the financial statements. This aligns perfectly with the definition of an Interim/Quarterly Report (IR). Q1 2024
2023-08-14 Japanese
内部統制報告書－第18期(2022/04/01－2023/03/31)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). This is a specific regulatory requirement in Japan that accompanies financial reporting to attest to the effectiveness of internal controls over financial reporting. Since it is a standalone regulatory filing regarding internal control compliance and does not fit into the other specific categories like 10-K or IR, it is best classified as a Regulatory Filing (RNS).
2023-06-23 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.